Healthy ReStart Intervention to Improve Health and Functioning
Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Sep 14, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Healthy ReStart Intervention study is designed to help adults with serious mental health conditions regain their active lives after major disruptions, such as those caused by the COVID-19 pandemic. This program combines health coaching, motivational interviewing, and online wellness tools to support participants in improving their health and daily functioning.
To be eligible for this study, participants must be at least 18 years old, diagnosed with a serious mental illness that affects their ability to function in everyday life, and must be members of a community mental health agency. They also need access to the Internet for online meetings and must be able to provide informed consent. Participants can expect to engage in supportive activities that help them set and achieve personal health goals, all while having the chance to connect with others in similar situations. This study is currently recruiting participants of all genders, and it offers a unique opportunity to work towards better health and well-being in a supportive environment.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 and older
- • Diagnosis of serious mental illness defined as a DSM 5 psychiatric disorder and moderate to severe functional impairment
- • Membership in a collaborating community mental health agency
- • Access to the Internet for online meetings
- • Able to provide informed consent
- Exclusion Criteria:
- • A cognitive impairment preventing informed consent
- • Unable to communicate in English
About University Of Illinois At Chicago
The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials